1 Objective: To describe the outcomes for patients treated at a single institution, who sustained 2 incomplete bisphosphonate-induced femoral fractures. fractures, only 64% were pain free at latest follow-up with only 18% of fractures demonstrating 18 radiographic evidence of healing at an average of 11 months (range: 6 to 24 months).
Introduction

29
Osteoporosis is a major health problem, causing nearly 50% of women and 25% of men 30 older than 50 years of age to sustain an osteoporosis-related fracture. of 5% to 8% in the lumbar spine and upper femur over 3 years. 1, 4 Bisphosphonates have become 37 a treatment of choice, with decreased fracture rates and prevention of postmenopausal bone loss. 4 
38
There have been several reports in recent literature suggesting a correlation between 39 long-term bisphosphonate therapy and the development of atypical subtrochanteric and 40 diaphyseal femoral fractures. [5] [6] This may be explained by chronic bone turnover suppression 41 which produces hypermineralized bone that is brittle and susceptible to fracture following low-42 energy trauma. 1 The association is now well recognized but since only a small subset of patients 43 is affected, bisphosphonates continue to be the mainstay of treatment in the management of 
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Clinical follow up for at least one year after initial diagnosis of incomplete femur fracture.
58
Incomplete fractures were defined by a pattern of focal lateral cortical thickening on radiographs,
59
with or without, obvious incomplete fracture line (Figure 1 There are several limitations to our study that are inherent in a retrospective case series.
192
Despite our many attempts to obtain complete data on all of the patients included in this study, 
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